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ABSTRACT 
Aim: To compare the microbiome of healthy (H) and diseased (P) peri-implant sites and 
determine the core peri-implant microbiome. 
Materials and Methods: Submucosal biofilms from 32 H and 35 P sites were analyzed using 
16S rRNA sequencing (MiSeq, Illumina), QIIME and HOMINGS. Differences between groups 
were determined using Principal Coordinate Analysis (PCoA), t-tests and Wilcoxon rank sum 
test and FDR-adjusted. The peri-implant core microbiome was determined. 
Results: PCoA showed partitioning between H and P at all taxonomic levels. Bacteroidetes, 
Spirochetes and Synergistetes were higher in P, while Actinobacteria prevailed in H (p<0.05). 
Porphyromonas and Treponema were more abundant in P and while Rothia and Neisseria were 
higher in H (p<0.05). The core peri-implant microbiome contained Fusobacterium, Parvimonas 
and Campylobacter sp. T. denticola and P. gingivalis levels were higher in P, as well as F. 
alocis, F fastidiosum and T. maltophilum (p<0.05). 
Conclusion: The peri-implantitis microbiome is commensal-depleted and pathogen-enriched, 
harboring traditional and new pathogens. The core peri-implant microbiome harbors taxa from 
genera often associated with periodontal inflammation. 
Clinical Relevance 
Scientific rationale for study: there is a need for a better understanding of the microbial etiology 
of peri-implant diseases. 
Principal findings: peri-implantitis sites were heavily colonized by well-known and newly 
proposed pathogens, including as-of-yet uncultivated taxa, while healthy peri-implant sites 
harbored more commensal taxa. The peri-implant core microbiome was enriched for 
Fusobacterium, Parvimonas and Campylobacter species. 
Practical implications: Better characterization of the peri-implant microbiome can improve the 
understanding of the etiology of peri-implant diseases. 
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Introduction 
The widespread use of implants has led to an increase in the number of cases of biofilm-
mediated peri-implant diseases, particularly peri-implantitis. Although long-term longitudinal 
studies indicate that implant therapy presents success rates of 95% - 99% (Moraschini et al., 
2015, Vigolo et al., 2015) recent publications have shown a prevalence of peri-implantitis of at 
least 20% (Derks et al., 2016b, Derks et al., 2016a, Derks & Tomasi, 2015, Mombelli et al., 
2012, Derks & Tomasi, 2014). It has been suggested that peri-implantitis progresses in non-
linear patterns, and for the majority of cases, the onset occurs within 3 years of function (Derks 
et al. 2016b). Peri-implantitis treatment is further complicated by the limited knowledge of its 
microbial etiology. While several studies have shown microbial similarities between 
periodontitis and peri-implantitis (Carcuac et al., 2016, Charalampakis & Belibasakis, 2015, 
Mombelli & Decaillet, 2011), others have implicated species not traditionally associated with 
periodontal/peri-implant diseases, such as Helicobacter pylori, Haemophilus influenzae, 
Staphylococcus aureus and Staphylococcus anaerobius in the etiology of peri-implantitis 
(Persson & Renvert 2014). The current poor understanding of the microbial etiology and 
pathogenesis of peri-implantitis may help explain the lack of effective treatment. 
Most of the publications that investigated the microbial profiles of peri-implantitis employed 
close-ended molecular approaches, which preclude the identification of potentially relevant taxa 
that are not targeted by the technique. The use of 16S rRNA Illumina sequencing can overcome 
this limitation by allowing an open-ended characterization of the microbiome under study 
(Caporaso et al., 2012, Frey et al., 2014, Smith & Peay, 2014), at a coverage depth 100 times 
greater than pyrosequencing, with a lower error rate and generating well over 10 times as many 
reads as 454 GS FLX (Nelson et al., 2014). Because it combines higher sequence quality at 
significantly lower cost per sequence, it has become the leading sequencing platform for human 
microbiome sequencing studies (Amarasekara et al., 2015). One limitation of 16S rRNA 
sequencing is that certain taxa cannot be distinguished with species-level taxonomic resolution 
when the commonly employed QIIME pipeline is used for the downstream taxonomic 
classification (Baker et al., 2003, Chakravorty et al., 2007, Ong et al., 2013, Pei et al., 2010, 
Wang & Qian, 2009). To manage this limitation, we analyzed the reads generated by MiSeq with 
HOMINGS in order to obtain species-level data. HOMINGS is an in silico probe-based platform 
that can detect more than 600 bacterial species from 16S rRNA reads (Belstrom et al., 2016a). 
The objective of the present investigation was to compare the microbiome of healthy (H) and 
diseased (P) peri-implant sites using 16S rRNA Illumina sequencing and HOMINGS and to 
determine the peri-implant core microbiome. 
Materials and Methods 
Patient recruitment 
This study was approved by the Ethical Review Committee of the Canton of Zürich, Switzerland 
(KEK-Nr: 2011-0159), and was conducted in accordance with the guidelines of the world 
Medical Association Declaration of Helsinki. Peri-implantitis patients were recruited as 
outpatients referred by private practitioners for the diagnosis and treatment of peri-implant 
disease at the Interdisciplinary Peri-implantitis Unit, in the Center of Dental Medicine at the 
University of Zürich. Patients presenting successful implants were recruited from the 
maintenance clinic at the same institution. Potential participants were informed about the aims of 
the study and were assured that their participation was voluntary. All participants provided 
written informed consent. The inclusion criteria were good medical health as evidenced by the 
medical history, being at least 18 years old and willing to participate in the study. Exclusion 
criteria were as follows: periodontal or peri-implant treatment within the past 12 months, 
systemic antibiotics use within the past 6 months, pregnancy or lactation, and heavy smoking 
(>20 cigarettes/day). 
Patients allocated to the peri-implantitis group presented at least one implant with post-insertion 
(i.e. at least one-year after loading) radiographic marginal bone loss of at least 2.0 mm mesially 
or distally, with concomitant bleeding on probing, according to the definitions presented in the 
European Workshop on Periodontology (Zitzmann & Berglundh, 2008). Radiographic bone
levels were recorded by measuring the distance from the implant shoulder to the first visible 
bone to implant contact at the mesial and distal aspect of each implant using periapical 
radiographs. 
The successful implants group included implants with healthy surrounding soft and hard tissues, 
determined by absence of pus and detectable radiographic bone loss, and functional loading for 
at least one year. Gender and age were recorded, as well as plaque index (PI), bleeding on 
probing (BOP), suppuration (SUP), probing pocket depth (PPD), clinical bone loss (BL in mm), 
width of keratinized mucosa (KM), implant wear time, time since last check up, implant system 
used and nature of reconstruction (single implant, fixed or removable). The clinical parameters 
were measured at 6 sites per implant (mesio-, mid-, disto-buccal and mesio-, mid-, disto-
lingual/palatal; except for KM, where the palatal sites were not measured). 
Submucosal biofilm sample collection and nucleic acid isolation 
Submucosal biofilm samples were collected from peri-implantitis sites (P) in peri-implantitis 
patients and from healthy peri-implant sites (H) of participants presenting successful implants. If 
multiple implants were present in a patient, one single implant was randomly selected for 
sampling. Samples were obtained from the site with the deepest PPD. Prior to sampling, the 
supramucosal areas of the implant and supra-structure were isolated using cotton rolls, air-dried 
and had the supramucosal biofilm removed. Submucosal biofilm samples were obtained with 
sterile Gracey curettes (Deppeler, Rolle, Switzerland). The sample was immediately placed in a 
micro-centrifuge tube containing 0.1 ml of RNAse-free TE buffer (10 mM Tris-HCl, 1 mM 
EDTA, pH 7.6) and stored at -80°C until analysis. 
Bacterial nucleic acids were isolated using the Masterpure DNA purification kit (Epicentre, 
Madison, WI, USA), preceded by an overnight incubation with lysozyme at 37°C. DNA quality 
and amount were determined using a spectrophotometer and the Picogreen dsDNA quantification 
assay (Invitrogen, Carlsbad, CA, USA). 
16S rRNA gene sequencing with Illumina sequencing 
Sample DNA was analyzed by sequencing the 16S rRNA gene V3-V4 hypervariable region 
using MiSeq (Illumina, CA), according to the protocol described by (Caporaso et al., 2011). In 
brief, 10-50 ng of DNA were PCR-amplified using the 341F/806R universal primers targeting 
the V3-V4 hypervariable region: 341F (forward) 
AATGATACGGCGACCACCGAGATCTACACTATGGTAATTGTCCTACGGGAGGCAGC
AG; 806R (reverse) CAAGCAGAAGACGGCATACGAGATTCCCTTGTCTCC 
AGTCAGTCAGCCGGACTACHVGGGTWTCTAAT, where the 'TCCCTTGTCTCC' region 
represents the appropriate barcode sequences and the underlined bases make the PCR products 
Illumina sequencing compatible. PCR samples were purified using AMPure beads and 100 ng of 
each barcoded library were pooled, purified and quantified using a bioanalyzer and qPCR. Then, 
12 pM of each library mixture spiked with 20% PhiX was loaded onto the MiSeq and sequenced. 
Samples that presented poor performance in the pre-sequencing PCR amplification step were 
amplified by multiple displacement amplification (Teles et al., 2007) using the Illustra 
GenomiPhi V2 DNA Amplification kit (GE Healthcare, USA). Quality control of the reads was 
performed using FastQC. The paired end reads were merged using Flash. 
Taxonomic assignment 
The reads generated using MiSeq were analyzed using the QIIME pipeline (Caporaso et al. 
2010). In brief, the paired-end reads were merged using Flash. The libraries were split in QIIME 
according to the barcodes used in the sequencing run and low-quality reads were filtered out and 
chimeras were removed using UCHIME. Operational taxonomic units (OTUs) were picked using 
the Human Oral Microbiome Database (HOMD) v13.2 as the reference database (Chen et al. 
2010) using a 97% similarity threshold. Taxonomy was assigned using the Ribosomal Database 
Project (RDP) classifier trained on the HOMD v13.2 database with assignments required to meet 
a >80% confidence threshold. The phylum and genus-level analyses were performed using 
QIIME. 
For species-level analyses only, we employed HOMINGS, an in silico 16S rDNA probe analysis 
that allows for species-level identification of sequencing datasets generated with MiSeq 
(http://homings.forsyth.org) (Gomes et al., 2015). Species-specific, 16S rRNA-based 
oligonucleotide “probes” were used in a Perl program based on text string search to identify the 
frequency of oral bacterial targets. HOMINGS comprises 671 oligonucleotide probes of 17 to 40 
bases that target 538 individual oral bacterial species/phylotypes or, in some cases, a few closely-
related taxa. (Belstrom et al., 2016a, Belstrom et al., 2016d). 
Statistical analysis 
The demographic and clinical characteristics of the study population were analyzed using the 
Fisher’s Exact Test or Student’s t-test. Effects of disease status on the peri-implant microbiome 
were examined using Principal Coordinate Analysis (PCoA). 
Significant differences in relative abundance (%) between the clinical groups were determined at 
the phylum, genus, and species levels. Raw read counts were rarefied to the minimum number of 
aligned reads. Only taxa that had at least 3 reads in at least 3 samples in both clinical groups after 
rarefication were considered. Significant differences between the healthy and peri-implantitis 
groups were determined by Wilcoxon rank sum test with FDR-adjusted p-values <0.05. This 
rarefication and determination of significance was repeated 100 times. Taxa that were significant 
in 95% of these iterations were further considered in the analyses. Interactions between those 
taxa and smoking, as well as implant type were assessed using ANOVA. 
The core microbiome of the dataset was determined based on taxa present with ≥0.1% relative 
abundance in ≥50% of all samples, as determined by HOMINGS (Abusleme et al., 2013). It was 
subdivided into 4 groups based on the taxa mean relative abundance in samples in each clinical 
category. Taxa that were present in ≥50% of samples in either the H or P groups, but were not 
part of the core microbiome considering all samples, constituted the healthy or peri-implantitis 
core microbiomes, respectively. 
Results 
Demographic and clinical characteristics of the subjects 
Eighty-two patients contributing with one implant per patient were initially included in the 
investigation. Fifteen patients were excluded due to issues with microbial sampling. Finally,  the 
analysis of demographic and clinical data from the sampled population showed that the groups 
comprising healthy (H, N=32) and diseased peri-implant sites (P, N=35) were well-balanced for 
age, gender, implant wear, implant location and type of restoration (Table 1). Non-smokers and 
smokers comprised 37.1% and 42.9% of the P group, respectively, whereas in the H group these 
were 71.9% and 21.9%, respectively (p=0.03). Straumann was the most frequently used implant 
system in both groups (71.9% in H and 47.1% in P), while other systems (i.e., not Straumann or 
Branemark) were more common in P (35.3%) than in H (3.1%) (p=0.003). Significant 
differences between the groups were observed for the clinical parameters that defined them 
(p<0.0001). 
Overall microbial sequencing results 
Fifteen samples (7 in disease, 8 in health) were excluded from analysis due to the small number 
of reads (<5,000). After quality control, chimera depletion and noise filtering, 7,297,772 reads 
(median/sample: 114,230; range: 5,055-212,299) were assigned into OTUs (1.7% of them 
remained unassigned) and most of them (73.52%) ranged from 408 to 428 bp in length. OTUs 
were classified into twelve phyla: Bacteroidetes (25.3%), Proteobacteria (18.4%), Firmicutes 
(16.7%), Actinobacteria (15.6%), Fusobacteria (15.6%), Spirochaetes (5.3%), Synergistetes 
(0.7%), Tenericutes (0.4%), TM7 (0.3%), SR1 (0.1%), Chloroflexi (0.01%) and GN02 (0.001%). 
These OTUs were further classified into 21 classes, 35 orders, 69 families and 94 genera, using 
QIIME. HOMINGS identified 85 genera and 210 species using species-specific “probes”. A 
complete list of species detected in H and P samples can be found in Supplemental Table 1. 
Microbial profiles of healthy and diseased peri-implant sites 
Diseased peri-implant sites presented higher diversity, compared to healthy sites (Supplemental 
Fig. 1a). Healthy (H) and diseased (P) peri-implant sites presented distinct microbial profiles at 
all taxonomic levels (Fig. 1a-c, Supplemental Fig. 1b). Diseased peri-implant sites were 
primarily colonized by members of the phyla Bacteroides, Spirochetes and Synergistetes, 
whereas healthy peri-implant sites mostly harbored taxa from the Proteobacteria and 
Actinobacteria phyla (p<0.05, FDR-adjusted) (Fig. 1a). The genera Porphyromonas (phylum 
Bacteroidetes), Treponema (phylum Spirochetes), Filifactor (phylum Firmicutes), 
Fretibacterium (phylum Synergistetes and Tannerella (phylum Bacteroidetes) were abundant in 
peri-implantitis and were present at a higher relative abundance than those found in the H group 
(p<0.05, FDR-adjusted). In contrast, Streptococcus (phylum Firmicutes), Veillonella (phylum 
Firmicutes), Rothia (phylum Actinobacteria) and Haemophilus (phylum Proteobacteria) had 
higher relative abundance in H sites (p<0.05, FDR-adjusted) (Fig. 1b). Peri-implantitis sites 
harbored higher levels of classic pathogens (Fig. 1c), such as Tannerella forsythia, Treponema 
denticola and Porphyromonas gingivalis (p<0.05, FDR-adjusted), as well as recently described 
new putative pathogens, such as Filifactor alocis, Fretibacterium fastidiosum and Treponema 
maltophilum. Implants adjacent to H sites were enriched for Rothia dentocariosa (Fig.1c). 
Analysis of the relative abundance of pathogenic and health-compatible species in individual 
implants (Fig. 2 a-c) showed that red complex species (T. forsythia, P. gingivalis and T. 
denticola) were present at high levels in most P samples compared to H samples (Fig. 2a), 
whereas the opposite was observed for species considered compatible with periodontal/peri-
implant health, such as R. dentocariosa, Streptococcus sanguinis and Veillonella dispar (Fig. 
2b). Furthermore, newly proposed periodontal pathogens, such as F. alocis, F. fastidiosum, 
Eubacterium saphenum and T. maltophilum and as-of-yet uncultured taxa Desulfobulbus sp ot 
041, Fretibacterium sp ot 360 and Peptostreptococcacea sp ot 091 and 369 (Fig. 2c) followed a 
colonization pattern similar to that of well-recognized periodontal pathogens (T. forsythia, P. 
gingivalis and T. denticola) (Fig. 2b). 
Next, we employed PCoA to assess the impact of peri-implant health and disease on the local 
microbiome. A clear distinction between the microbial composition of H and P implants at all 
taxonomic levels was observed (Fig. 3a-c). Even though it was not the primary objective of the 
present study, we also explored the potential impact of smoking status and implant system used 
on the peri-implant microbiome. When the smoking status was incorporated in the analysis (Fig. 
3b), it became apparent that the composition of the microbiome of current smokers in the H 
microbiome was closer to that of peri-implantitis cases than to that observed in successful 
implants.  The impact of the implant system on the local microbiome seemed to be less evident 
(Fig. 3c). 
Because our results indicated that smoking and implant type could be possible confounders when 
the microbiome of peri-implant health and disease was compared, potential interactions between 
these parameters were also included in our statistical model. The results revealed an interaction 
between smoking and disease status for T. socranskii and Eubacterium saphenum, interactions 
between smoking and implant type for T. maltophilum and E. saphenum, and interactions 
between disease status and implant type for T. maltophilum. 
The commensal and pathogenic microbial profiles of H and P groups became clearer with the 
analysis of the peri-implant core microbiome (Fig. 4). Taxa typically known as host-compatible, 
such as Veilonella parvula, S. sanguinis and Rothia sp. were part of the peri-implant health core, 
while the red complex species (T. forsythia, P. gingivalis and T. denticola), as well as “new 
putative pathogens” Filifactor alocis, Treponema maltophilum and Fretibacterium_fastidiosum 
comprised the peri-implantitis core. 
The use of HOMINGS complemented the QIIME data, as it allowed for the species-level 
analysis of taxa that could not be “speciated” by QIIME. For instance, QIIME identified 
additional taxa from the genus Porphyromonas (Group_4) in the peri-implantitis core whereas 
HOMINGS classified some of them as Porphyromonas endodontalis. Similarly, it identified 
Campylobacter gracilis and Veillonella dispar as members of the same core, while QIIME 
indicated the presence of members of the genera Campylobacter (phylum Proteobacteria) and 
Veillonella (Fig. 4, Supplemental Fig. 2). 
Because HOMINGS is a new bioinformatics approach for the analysis of sequencing data, we 
compared its results with those obtained with QIIME, a more established pipeline. Since QIIME 
does not allow complete species-level taxonomic resolution, genus-level comparisons were 
made. Results were quite comparable and most taxa that differed between peri-implant health 
and disease reported in Fig. 1a-c were also observed in the QIIME pipeline (Supplementary Fig. 
3a-c, Supplemental Table 2). 
Discussion 
The use of next generation sequencing to explore the microbiome of healthy and diseased peri-
implant sites allowed us to expand the breadth of knowledge of the etiology of this disease. We 
used  QIIME and HOMINGS to analyze Illumina MiSeq-generated reads and demonstrated that 
QIIME and HOMINGS agreed in large part at the genus level (Supplemental Table 2). We 
showed that those pipelines should be complementary: to a certain extent QIIME provided 
greater breadth of classification whereas HOMINGS provided increased precision. We propose 
that using two accepted and complementary techniques will shed more light on a difficult (and 
somewhat ill-defined) classification. 
In the present study, we were able to determine major microbial differences between peri-
implant healthy and diseased sites and delineate the core microbiome of peri-implant health and 
peri-implantitis. The microbial differences between the two clinical groups were clear at all 
taxonomic levels. Peri-implantitis sites harbored greater levels of members of the phyla 
Bacteroidetes, Spirochetes, Synergistetes and Tenericutes, as well as taxa from the genera 
Porphyromonas, Treponema, Filifactor and Fretibacterium. Using fluorescence in situ 
hybridization (FISH) combined with epifluorescence microscopy to analyze samples from the 
same individuals, Belibasakis and co-workers (Belibasakis et al., 2016) also found elevated 
levels of Synergistetes and Spirochetes in peri-implantitis sites. Furthermore, diseased sites were 
heavily colonized by traditional pathogens, such as red complex species, as well as newly 
proposed pathogenic taxa (Perez-Chaparro et al., 2014), such as F. alocis, F. fastidiosum and 
Desulfobulbus sp. oral taxon 041, which is currently uncultured. Conversely, Streptococci were 
highly abundant in healthy implants. Our findings corroborate previous studies suggesting 
similarities between peri-implant associated microbiota and the periodontal microbiota. Using 
checkerboard DNA-DNA hybridization, (Shibli et al., 2008) found high mean counts of all red 
complex species in peri-implantitis samples, while host-compatible microorganisms were 
reduced. Our results are also in line with early cloning and sequencing studies of the peri-implant 
microbiome, in which Porphyromonas, Fusobacterium and Filifactor species were abundant (da 
Silva et al., 2014, Koyanagi et al., 2013). 
Several of the traditional pathogens as well as newly proposed pathogenic taxa were detected in 
overall low mean relative abundance levels in our study (Fig. 1c, 2a, 2c). Albeit, similar to levels 
reported by others (Maruyama et al., 2014), the pathogenic capacity of low level taxa might be 
intriguing. However, it is well-accepted that the presence of taxa in low abundance does not deny 
their potential importance. In fact, that is the tenet of the keystone-pathogen hypothesis, which 
holds that “certain low-abundance microbial pathogens can orchestrate inflammatory disease by 
remodeling a benign microbiota into a dysbiotic one” (Hajishengallis & Lambris, 2012). 
In our peri-implantitis samples, we could not confirm reports of the presence of bacteria typically 
detected in infections of implanted medical devices (Mombelli & Decaillet, 2011) or species not 
traditionally associated with periodontitis, including Helicobacter pylori, Staphylococcus aureus 
and Staphylococcus anaerobius (Persson & Renvert, 2014), although H. influenza was part of the 
peri-implant core microbiome. Our results are also in contrast with those of (Kumar et al., 2012). 
Using pyrosequencing, the authors found that peri-implantitis harbored lower levels of 
Prevotella and Leptotrichia and higher levels of Actinomyces, Peptococcus, Campylobacter, 
non-mutans Streptococcus, Butyrivibrio and Streptococcus mutans than healthy implants. A 
subsequent paper from the same group (Dabdoub et al., 2013) reported that Staphylococcus was 
significantly associated with implant infection and that red complex pathogens were found in 
only 37 % of the peri-implantitis biofilms. 
The discrepancies presented above may be, in part, due to the use of distinct sample collection 
methods. While in our study we employed curettes, several publications on the peri-implant 
microbiome have used paper points (Dabdoub et al. 2013, Tsigarida et al. 2015). However, this 
method has been demonstrated to harbor DNA of its own (van der Horst et al., 2013), which can 
alter the representation of the microbiome under study, particularly when sensitive sequencing 
platforms are used. Thus, their use has been discouraged, in favor of curettes (van der Horst et al., 
2013). The above discrepancies may also be due to differences in sequencing platforms and 
bioinformatics pipelines. MiSeq Illumina sequencing has recently outperformed pyrosequencing, 
allowing an inexpensive and deeper coverage of the microbiome (Caporaso et al., 2012, Frey et 
al., 2014, Nelson et al., 2014, Smith & Peay, 2014). MiSeq technology has a lower error rate 
compared to pyrosequencing and generates over 10 times as many reads as 454 GS FLX (Nelson 
et al., 2014). Thus, it has become the leading sequencing platform, particularly for human 
microbiome sequencing studies (Amarasekara et al., 2015). Furthermore, since our goal was to 
define a core microbiome commonly present on implants, and those frequently associated with 
peri-implant health or disease only, we used a very conservative approach to assign taxa as 
present in our samples. For instance, taxa were removed from consideration if they did not have 
at least 3 reads in at least 3 samples in both the healthy and peri-implantitis groups after 
rarefication. The goal was to “weed out” species belonging to the so-called “rare biosphere”. The 
idea of determining taxa consistently found in human disease conditions or in specific 
environments, the so-called core microbiome, has been adopted by many in microbial ecology 
(Human Microbiome Project Consortium 2012, Backhed et al., 2012, Shade & Handelsman, 
2012). The use of this approach might have also contributed to differences between our results 
and those from previous studies. 
While the healthy and peri-implantitis cores were rich in health-compatible and pathogenic taxa, 
respectively, we observed that the peri-implant microbiome core contained members of genera 
Fusobacterium, Parvimonas and Campylobacter. Interestingly, those genera harbor species 
known to be associated with periodontal inflammation (Socransky & Haffajee, 2005), such as F. 
nucleatum, P. micra and C. rectus, all of which are members of the orange complex. Hence, it is 
plausible that implants are colonized by bacterial species that predispose the adjacent tissues to 
inflammation. 
In order obtain species-level taxonomic resolution from MiSeq sequencing, we employed 
HOMINGS, an in silico 16S rDNA probe analysis that allows the identification of more than 600 
oral bacterial species/phylotypes from MiSeq-generated reads (Belstrom et al., 2016a, Belstrom 
et al., 2016d). HOMINGS has been validated and has been increasingly used in oral 
microbiology studies (Gomes et al., 2015, McIntyre et al., 2016, Mougeot et al., 2017, Mougeot 
et al., 2016, Rudney et al., 2015, Timby et al., 2017, Belstrom et al., 2016a, Belstrom et al., 
2016b, Belstrom et al., 2016c, Belstrom et al., 2016d, Belstrom et al., 2017). Yet, due to the 
novelty of the use of HOMINGS, we validated our findings by comparing QIIME and 
HOMINGS genus-level data (Supplemental Table 2). The results were quite consistent, 
indicating the robustness of our analytical pipelines, and the validity of the HOMINGS 
technique. 
The combination of these approaches allowed us to detect newly proposed pathogens, such as P. 
endododontalis, F. alocis and F. fastidiosum and Desulfobulbus sp oral taxon 041, all with 
significant virulence properties. P. endodontalis can induce osteoclastogenesis (Ma et al., 2017, 
Yu et al., 2015), F. alocis and P. endodontalis present robust NOD1 and NOD2 stimulatory 
activity, respectively (Marchesan et al., 2016) and F. alocis has oxidative stress resistance, 
neutrophil and macrophage evasion, adhesion and invasion among its main virulence factors 
(Aruni et al., 2014). In addition, transcriptional activity analysis of the periodontal microbiome 
and the human host in health and chronic periodontitis showed that the upregulation of bacterial 
chemotaxis, flagellar assembly, type III secretion system, and type III CRISPR-Cas system was 
driven not only by the red-complex pathogens, but also by candidate pathogens, including F. 
alocis and F. fastidiosum (Deng et al., 2017). Finally, our results suggest that phylotypes, such as 
Desulfobulbus sp HOT 041, might also contribute to the development of peri-implantitis. 
Culture-independent studies have demonstrated the association of this phylotype with 
periodontitis (Camelo-Castillo et al., 2015, Oliveira et al., 2016), however information on its 
virulence properties is scarce due to its status of “as-of-yet uncultured organism”. Still, the 
isolation and sequencing of single cells of oral Desulfobulbus (n = 7) identified genes associated 
with several categories of putative virulence factors, including chemotaxis, flagellum 
biosynthesis motor proteins secretion, iron acquisition, stress response, evasion, proteases, and 
adhesion. Collectively, these findings support the pathogenic role of newly identified pathogens 
and that they merit further examination of their potential role as etiologic agents of peri-
implantitis. 
The peri-implantitis group included more smokers than the peri-implant healthy group, which is 
in line with the literature, as smoking is a well-known risk factor for peri-implantitis (Heitz-
Mayfield, 2008). Part of the deleterious effects of smoking on implant survival might be due to 
its impact on the peri-implant microbiota. As demonstrated by (Tsigarida et al., 2015), smoking 
shapes the peri-implant microbiome even in clinical health, promoting a pathogen-rich 
community depleted of commensals. This phenomenon was also observed in the present study, 
where healthy implants from non-smokers had microbial profiles distinct from those found in 
current smokers, which appeared to be more similar to a peri-implantitis microbiome (Fig. 3 a-c). 
This finding could help justify the differences in the core microbiomes in peri-implant health and 
disease. To examine this possibility, our statistical models tested for interactions between 
smoking and disease status. We only found interactions between smoking and disease status for 
T. socranskii and E. saphenum, thereby supporting the notion that the main driver of differences 
in the core microbiome between peri-implant health and peri-implantitis was the disease status. 
Due to the scarce literature on the comparison of the microbiomes of different implant systems, 
we also explored their impact on the local microbiome. Straumann implants were the most 
frequently used in both groups (Table 1), but the implant system did not modulate the microbial 
composition of peri-implant biofilms (Fig. 3 b-c). 
Although it was not our goal to compare the peri-implant and periodontal microbiota, our results 
support the notion that both are similar. Using pyrosequencing, Maruyama and co-workers 
(Maruyama et al., 2014) performed this comparison and concluded that the core microbiome 
associated with these clinical conditions differed, and suggested that they presented “different 
causative pathogens”. However, only Prevotella nigrescens had significantly higher relative 
abundance in peri-implantitis compared to periodontitis, while Peptostreptococcaceae [XI] [G-
4], sp. HOT369 and Desulfomicrobium orale were more abundant in periodontitis. Furthermore, 
their PCoA did not demonstrate that the two diseases differed in their community structure. 
Measures of biodiversity were also similar in peri-implantitis and periodontitis. Our results were 
in accordance with theirs that reported that P. gingivalis, T. denticola and T. socranskii were 
abundant and prevalent in most samples of peri-implantitis. 
The present study suggests that the peri-implant microbiome is quite distinct in health and 
disease. Peri-implantitis sites showed an enrichment for pathogens, at the expense of a depletion 
of host-compatible species. Well-recognized periodontal pathogens as well as newly proposed 
pathogenic taxa, several of which have not yet been cultivated, were associated with peri-implant 
disease sites. The core peri-implant microbiome contained members of genera Fusobacterium, 
Parvimonas and Campylobacter sp., potentially including pathogenic species such as F. 
nucleatum, P. micra and C. rectus. Our findings are clinically relevant, in that based on these 
results, it can be postulated that close surveillance, periodic maintenance as well as early 
diagnosis of peri-implantitis and immediate intervention are critical for the long-term retention of 
implants 
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FIGURE LEGENDS 
Figure 1. Box plots of differences in microbial relative abundance between samples from 
healthy and peri-implantitis (disease) sites at the level of phylum (a), genus (b), and species 
(c). Phylum-, genus- and species-level data were obtained using HOMINGS. Taxa were sorted 
according to decreasing relative abundance in subjects with peri-implantitis. Only taxa that were 
significantly different between the healthy and peri-implantitis groups (with FDR-adjusted p-
values <0.05) in more than 95% of the 100 iterations performed were plotted. 
Figure 2. Relative abundance of pathogenic and health-compatible species in individual 
implants. Graphs show mean relative abundance (%) for (a) well-recognized periodontal 
pathogens, (b) putative commensals and (c) newly proposed pathogenic taxa. Only species that 
were significantly different between the healthy and peri-implantitis groups (with FDR-adjusted 
p-values <0.05) in more than 98% of the 100 iterations performed were plotted. Each bar 
represents one individual healthy (blue) or diseased (red) implant. 
Figure 3. Principal Coordinate Analysis (PCoA) of the microbial composition of samples 
according to disease status (a), smoking habit (b) and brand of implant (c). Graphs represent 
the PCoA plots of Bray–Curtis distances based on species level data generated with HOMINGS. 
Samples from subjects presenting healthy (blue) and diseased (red) peri-implant sites (a) are 
plotted according to smoking habit (b) and type of implant (c).  
Figure 4. Core Microbiome. Taxa that were present with ≥ 0.1% relative abundance in ≥ 50% 
of all samples according to HOMINGS results constitute the core microbiome (blue). Samples 
were divided into those representing healthy or peri-implantitis. The core microbiome was 
subdivided into 4 groups based on the mean relative abundance of the taxa in samples in each 
clinical category. Taxa that were present in ≥ 50% of samples in a single category, but were not 
part of the core microbiome considering all samples, constituted the Healthy (green) or Peri-
implantitis (red) core microbiomes. Taxa in those core microbiomes were sub-grouped based on 
the mean relative abundance of the taxa in samples in each clinical group. Taxa in bold were 
present in ≥ 75% of all samples (Core).  
Supplemental Figure 1. Alpha and Beta Diversity. a) Measure of alpha diversity in healthy 
and peri-implantitis sites as determined by the Chao 1 index. b) Beta diversity represented by 
Principal Component Analysis plots of unweighted Unifrac distances. 
Supplemental Figure 2. Core Microbiome. Taxa that were present with ≥ 0.1% relative 
abundance in ≥ 50% of all samples according to QIIME results constitute the Core Microbiome 
(blue). Samples were divided into those representing healthy or peri-implantitis. The Core 
Microbiome was subdivided into 4 groups based on the mean relative abundance of the taxa in 
samples in each clinical category. Taxa that were present in ≥ 50% of samples in a single 
category, but were not part of the Core Microbiome considering all samples, constitute the 
Healthy (green) or Per-iimplantitis (red) Core Microbiomes. Taxa in those Core Microbiomes 
were sub-grouped based on the mean relative abundance of the taxa in samples in each clinical 
group. Taxa in bold were present in ≥ 75% of all samples (Core). Taxa that could not be resolved 
to the species-level are presented as groups, described as follows:  
1. Parvimonas_Group_16: Parvimonas_micra, sp_oral_taxon_110, sp_oral_taxon_393
2. Treponema_Group_27: Treponema_socranskii, sp_oral_taxon_268, 
sp_oral_taxon_269
3. Veillonella_Group_19: Veillonella_atypica, denticariosi, dispar, parvula
4. Neisseria_Group_21: Neisseria_flava, mucosa, oralis, pharynges, sicca, 
sp_oral_taxon_016, sp_oral_taxon_018, subflava
5. Porphyromonas_Group_4: Porphyromonas_endodontalis, sp_oral_taxon_285, 
sp_oral_taxon_395
6. Fretibacterium_Group_28: Fretibacterium_sp_oral_taxon_358, sp_oral_taxon_359,
sp_oral_taxon_360, sp_oral_taxon_361, sp_oral_taxon_362, sp_oral_taxon_452,
sp_oral_taxon_453
Supplemental Figure 3.  Box plots of differences in microbial relative abundance between 
samples from healthy and peri-implantitis sites at the level of phylum (a), genus (b), and 
species (c). Phylum, genus and species-level data were obtained using QIIME. Taxa were sorted 
according to decreasing relative abundance in subjects with peri-implantitis. Only taxa that were 
significantly different between the healthy and peri-implantitis groups (with FDR-adjusted p-
values < 0.05) in more than 95% of the 100 iterations performed were plotted. 
Table 1: Characteristics of the peri-implant sites sampled. 
Parameters Healthy (n = 32) Peri-implantitis (n = 35) p-value 
Patient age (years ± SD) 57 ± 16 59 ± 14 0.509 
Gender (M/F) 10/22 12/23 1 
Implant wear (years ± SD) 6.3 ± 4.4 7.3 ± 3.6 0.312 
Bone loss (mm ± SD) 0.03 ± 0.18 6.7 ± 2.4 <0.0001 
Suppuration at any site (# subjects/total) 0/32 18/35 <0.0001 
Suppuration proportion of sites per subject 0 0.35 ± 0.41 <0.0001 
PD (average of 6 sites) (mm ± SD) 3.1 ± 0.5 7.0 ± 2.5 <0.0001 
PD (at site sampled) (mm ± SD) 3.2 ± 0.7 7.5 ± 3.0 <0.0001 
BOP at any site (# subjects/total) 19/32 34/35 0.0002 
BOP proportion of sites per subject 24 ± 29 80 ± 26 <0.0001 
PI at any site (# subjects/total) 13/32 24/35 0.028 
PI proportion of sites per subject 12 ± 19 45 ± 38 <0.0001 
Keratinized mucosa (average of 5 sites) (mm ± SD) 3.3 ± 1.5 2.2 ± 1.8 0.009 
Keratinized mucosa (at site sampled) (mm ± SD) 3.3 ± 2.1 2.3 ± 2.0 0.034 
Location of implant (maxilla/mandible) 16/16 18/17 1 
Location of implant (posterior/anterior) 24/8 29/6 0.551 
Type of restoration (fixed/removable) 30/2 32/3 1 
Smokers (%) 0.033 
non-smoker 71.9% 37.1% 
former smoker 3.1% 11.4% 
current smoker 21.9% 42.9% 
missing data 3.1% 8.6% 
Pack years (years ± SD) 29 ± 22 (n=7) 19 ± 14 (n=15) 0.247 
Implant System (%) 0.003 
Straumann 71.9% 47.1% 
Branemark 25.0% 17.7% 
Other 3.1% 35.3% 
Note: PD=pocket depth, BOP=bleeding on probing, PI=plaque index, SD=standard deviation. 



